Morgan Stanley (NYSE: MS) reported its financial results for the quarter ended March 31, 2020 today.
Morgan Stanley posted a 30% drop in earnings due to lower top-line growth. Over the past two months, the company has witnessed more market volatility, uncertainty and anxiety as a result of the devastating COVID-19 than at any time since the financial crisis.
The company has voluntarily ceased its share repurchase program in the first quarter to better support clients with lending and other services during the global pandemic. The Institutional Securities segment experienced the impact of the deterioration of credit in the global markets while market headwinds impacted Wealth Management. The decline in global asset prices hurt the Investment Management segment.
Past Performance
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
